GA Telesis and Tokyo Century Corporation Launch $1 Billion New Technology Engine Leasing Initiative
GA Telesis and Tokyo Century Corporation announced today the launch of a new technology engine financing initiative focusing on a select group of new technology jet engines. GA Telesis has been an industry leading engine lessor since its inception in 2002 and has consummated well over 1,000 engine transactions. The new joint initiative will enhance GA Telesis’ current technology engine leasing business by implementing a more competitive cost of capital for longer-term and more structured transactions.
The target portfolio will consist of the following engine models: General Electric GEnx, Rolls-Royce Trent 1000 and Trent XWB, Pratt & Whitney GTF and CFM International LEAP engines. GA Telesis and Tokyo Century are targeting the origination and closing of $1 billion new-technology engine transactions over the next 24 months.
“This is an unprecedented time in the history of aviation where each engine manufacturer is delivering a new technology engine simultaneously," said Abdol Moabery, President & CEO of GA Telesis. “With over ten thousand new-technology engines in the backlog, we are prepared to help our airline customers by providing them a customized financing solution to meet their needs,” he added.
“As a company that has built a global reputation for its leasing products, the initiative will continue to define Tokyo Century Corporation’s commitment to the aviation industry,” said Koichi Nakajima, Deputy President, Director and Executive Officer of Tokyo Century Corporation. We are very enthusiastic about the market’s demand for leasing products such as this and we are committed to growing this,” he added.
About GA Telesis
GA Telesis is a global provider of integrated aviation solutions serving the aerospace industry. The Company helps its customers achieve higher levels of performance by creating custom-tailored, multi-faceted solutions integrating its financial asset structuring expertise with component supply chain solutions, jet engine , aircraft systems and aerostructures MRO services. GA Telesis serves over 2,000 customers on six continents supporting all Airbus, Boeing, Bombardier and Embraer aircraft as well as CFM International, General Electric, International Aero Engines, Pratt & Whitney, and Rolls-Royce jet engines.
About Tokyo Century Corporation
Tokyo Century Corporation is a highly specialized and unique financial services company that pioneers new business fields combining finance, services and business expertise, working alongside customers in pursuit of their growth and goals. Through its four core businesses (Equipment Leasing, Specialty Financing, Domestic Automobile Financing, and International Business) Tokyo Century seeks to provide solutions that help increase the corporate value of customers. The Company is a 20% shareholder of GA Telesis.
For further information: please contact: firstname.lastname@example.org
GA Telesis, LLC
Cathy Moabery, 954-676-3111
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
AZ-UNIVERSAL-LASER18.7.2018 14:07 | pressemeddelelse
Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials
OH-STERIGENICS18.7.2018 14:02 | pressemeddelelse
Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK
SMITHS-DETECTION18.7.2018 11:07 | pressemeddelelse
Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport
NORSK-TITANIUM18.7.2018 09:02 | pressemeddelelse
Norsk Titanium Continues to Grow in the State of New York
FRVR18.7.2018 09:02 | pressemeddelelse
FRVR skaffer 3 millioner dollars, anført af Accel, til at bygge og distribuere spil til spillere på alle platforme.
EUSA-PHARMA18.7.2018 08:02 | pressemeddelelse
EUSA Pharma Announces Acquisition of Global Rights to SYLVANT® (siltuximab) from Janssen Sciences Ireland UC for $115 Million
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum